Digital Artefacts

Iowa City, United States Founded: 1999 • Age: 27 yrs Acquired By Clinical Ink
Provider of the clinical trial management platform

About Digital Artefacts

Digital Artefacts is a Healthcare company based in Iowa City (United States) founded in 1999, and was acquired by Clinical Ink in November 2021. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and IQVIA; 2 of its 3 listed competitors have raised funding.

Company details

Provider of the clinical trial management platform. The platform offers end-to-end clinical trial management solutions such as patient recruitment management, patient consent and study management, study design services in various functionalities such as cognitive, movement, autoimmune, oncology, and much more. Also, it offers tools for patient engagement management, collection of participant data, cognitive testing, and patient clinical data security management.

  • Headquarters Iowa City, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website digitalartefacts.com
  • Social LinkedIn X
  • Acquired by Clinical Ink (Nov 2021)
Key Metrics

Funding Insights of Digital Artefacts

  • Total Rounds 2
  • Last Round Grant β€” $173,877
  • First Round $1.3M

    (Apr 2013)

  • Investors Count 1

All 2 funding rounds of Digital Artefacts with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2015$173,877Grant––
Apr 2013$1.3MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in Digital Artefacts

Digital Artefacts has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Clinical Ink and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Paperless eSource and patient engagement solutions for clinical trials
2006clinicalink.comWinston-salem, United States
Premium access

Investor details for Digital Artefacts

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Digital Artefacts

4 dated milestones of Digital Artefacts across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Digital Artefacts is founded.
  2. Funding First funding round of $1.3M.
  3. Funding Latest funding round, Grant, of $174K.
  4. Exit Acquired by Clinical Ink.

Competitors of Digital Artefacts

Digital Artefacts has 3 listed competitors in our database, 2 of them funded. They include Medidata, Verily and IQVIA.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
iqvia.com1982Durham, United States88,000
Clinical research and commercialization solutions are provided for healthcare.
Premium access

Detailed competitors of Digital Artefacts

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Digital Artefacts (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Digital Artefacts

Premium access

Complete news archive for Digital Artefacts

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digital Artefacts

Digital Artefacts was founded in 1999 and raised its 1st funding round 14 years after it was founded.

Digital Artefacts is headquartered in Iowa City, United States. It is registered at Iowa City, Iowa, United States.

Provider of the clinical trial management platform. The platform offers end-to-end clinical trial management solutions such as patient recruitment management, patient consent and study management, study design services in various functionalities such as cognitive, movement, autoimmune, oncology, and much more. Also, it offers tools for patient engagement management, collection of participant data, cognitive testing, and patient clinical data security management.

Digital Artefacts's top competitors include Medidata, Verily and IQVIA.

Digital Artefacts has 2 investors. Key investors include Clinical Ink, and HHS.

Yes. Digital Artefacts was acquired by Clinical Ink in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available